IRCT20201225049826N1
Recruiting
未知
Evaluating the effect of autologous platelet-rich plasma on the improvement of therapeutic effectiveness of the classic approach to anal
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients diagnosed with anal fissure
- •Consent for entering to the study
Exclusion Criteria
- •Patients with inflammatory bowel disease or other conditions which can cause secondary anal fissure
- •Patients with diabetes
- •Patients with immune deficiency
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Assessment the effect of using autologous platelet rich plasma (PRP) in prevention of hypertrophic scarIRCT20201007048955N2Clinical Research Development Center50
Not yet recruiting
Not Applicable
Efficacy of autologous platelet rich plasma (PRP) in prevention of hypertrophic scarIRCT20201007048955N1Clinical Research Development Center50
Not yet recruiting
Not Applicable
Comparing the beneficial effects of patients own Platelet rich plasma therapy and topical minoxidil 5%lotion in males with hairloss problems due to male hormones.CTRI/2020/05/025389Jawaharlal Institute of Postgraduate Medical Education and Research
Recruiting
Phase 3
Efficacy of autologous platelet-rich plasma and laser acupuncture in the treatment of non-obstructive azoospermiaIRCT20111121008146N43Shahid Beheshti University of Medical Sciences30
Active, not recruiting
Phase 1
Efficacy of plasma injections, and extracorporeal shock wave therapy, in thetreatment of work –related lateral epicondylitisThe epicondylitis is an overuse injury, in most cases, is a self-limited course andresponds well to conservative treatment. Its etiology is degenerative and is relatedto a repetitive overuse and underlying tendinopathy.Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2018-002650-67-ESIbermutuamur (Mutua Colaboradora con la Seguridad Social nº 274)66